NasdaqGS - Nasdaq Real Time Price USD

SOPHiA GENETICS SA (SOPH)

Compare
3.3800
-0.0500
(-1.46%)
At close: January 14 at 4:00:00 PM EST
3.2500
-0.13
(-3.85%)
After hours: 7:57:48 PM EST

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 15.85M
Earnings -18.44M
Q4'23
Q1'24
Q2'24
Q3'24
-20M
-10M
0
10M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

5.00
7.00 Average
3.3800 Current
11.00 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 2222
Avg. Estimate -0.15-0.19-0.75-0.62
Low Estimate -0.16-0.23-0.88-0.67
High Estimate -0.14-0.15-0.63-0.57
Year Ago EPS -0.28-0.14-0.93-0.75

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 5566
Avg. Estimate 17.71M17.11M65.14M74.78M
Low Estimate 17.4M16.3M64.9M70.9M
High Estimate 18.07M17.7M65.51M79.9M
Year Ago Sales 17.05M15.78M62.37M65.14M
Sales Growth (year/est) 3.91%8.41%4.44%14.80%

Earnings History

Currency in USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. -0.17-0.21-0.2-0.18
EPS Actual -0.28-0.14-0.15-0.21
Difference -0.120.070.05-0.03
Surprise % -71.76%34.24%26.83%-15.22%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate -0.15-0.19-0.75-0.62
7 Days Ago -0.17-0.2-0.78-0.62
30 Days Ago -0.17-0.2-0.78-0.62
60 Days Ago -0.17-0.18-0.71-0.57
90 Days Ago -0.17-0.18-0.71-0.56

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days --1----
Up Last 30 Days --1----
Down Last 7 Days 1--11
Down Last 30 Days 1112

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
SOPH 47.07%-37.58%18.63%17.88%
S&P 500 8.58%11.41%13.97%13.43%

Upgrades & Downgrades

Initiated Craig-Hallum: Buy 12/18/2024
Maintains RBC Capital: Outperform to Outperform 8/7/2024
Initiated Guggenheim: Buy 6/27/2024
Maintains BTIG: Buy to Buy 3/6/2024
Reiterates RBC Capital: Outperform to Outperform 3/6/2024
Reiterates RBC Capital: Outperform to Outperform 1/12/2024

Related Tickers